VAXXINITY A (VAXX) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 74 199 sessions, October 21, 2025 to October 22, 2026
- Largest daily move
- +54900% close of September 17, 2026
- 1-year change
- +0% closing prices, October 21, 2025 to October 22, 2026
- 1-month change
- +0% closing prices, September 22, 2026 to October 22, 2026
Company Description
VAXXINITY A (OTC: VAXX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $5.5M.
VAXX has gained 0.0% over the past year. The last closing price was $0.0001.
For FY2023, VAXXINITY A reported net income of -$56.9M and diluted earnings per share of -$0.45.
This page collects what Stock Titan holds for VAXX, including price data, latest news, financial highlights, and short interest trends.
Stock Performance
VAXXINITY A (VAXX) closed at $0.0001 on October 22, 2026. Over the past 12 months, the price has gained 0.0%.
VAXX Metrics & Rankings
Price returns through October 22, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
VAXXINITY A has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, clinical trial, earnings. View all VAXX news →
SEC Filings
Financial Highlights
operating income reached -$58.3M, and net income was -$56.9M. Diluted earnings per share stood at -$0.45. The company generated -$57.2M in operating cash flow. The current ratio was 1.89, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in VAXXINITY A (VAXX) currently stands at 167.3 thousand shares, down 0.2% from the previous reporting period, representing 0.1% of the float.
Days to Cover History
Days to cover for VAXXINITY A (VAXX) currently stands at 34.4 days, up 273.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 547.4%. Across the settlements charted above, it has ranged from 1.9 to 99.8 days.
VAXX Company Profile & Sector Positioning
VAXXINITY A (VAXX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing VAXX often look at related companies in the same sector, including BIOPHYTIS SA (BPTSY), ORGENESIS INC (ORGS), KANE BIOTECH INC (KNBIF), BIOXYTRAN INC (BIXT), and ASEP MEDICAL HOLDINGS INC (SEPSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VAXX's relative position within its industry.